Delivering world-class patient support programs for the biopharmaceutical and healthcare industries through leading technologies, high-touch nurse call centers
Mount Laurel, NJ
Joined January 2025
- Tweets414
- Following476
- Followers42
- Likes86
Administrative burden doesn't end when a form is submitted.
Provider teams still face documentation, payer questions, appeals, and follow-up. Patient support programs help clarify ownership and next steps, reducing gaps that pull time away from care.
servahealth.com/patient-supp…
Patients may be finding clinical trials online, but that does not mean online is where they most want the conversation to start.
Awareness matters, but trust still matters just as much. clinicalleader.com/doc/most-…
#ClinicalTrials #PatientRecruitment
Cybersecurity threats can disrupt more than IT systems. They can interrupt patient communication and clinical trial operations.
Healthcare teams need clear verification steps, downtime plans, and communication workflows.
servahealth.com/patient-supp…
#HealthcareCybersecurity
Provider teams should not have to carry every access step alone.
Patient support programs can help organize prior auth, documentation, affordability, pharmacy coordination, and follow-up.
servahealth.com/patient-supp…
#PatientSupport #PatientAccess
Clinical trial recruitment often assumes patients already have a confirmed diagnosis.
For rare and complex conditions, that assumption can leave many potential participants out before screening even begins.
clinicaltrialvanguard.com/ne…
#ClinicalTrials #PatientRecruitment
Provider teams should not have to carry every access step alone.
Patient support programs can help organize prior auth, documentation, affordability, pharmacy coordination, and follow-up.
servahealth.com/patient-supp…
#PatientSupport #PatientAccess
As trial data volumes grow, AI may help teams move faster. But in regulated environments, credibility depends on context of use, oversight, and documentation that can stand up to review.
clinicaltrialvanguard.com/ne…
#ClinicalTrials #AI #ClinicalOperations #RegulatoryAffairs
Cell and gene therapy access is shaped long before approval.
For sponsors, the path to access starts early.
Worth a read:
contractpharma.com/exclusive…
#CellAndGeneTherapy #PatientAccess #ClinicalTrials #Biopharma
More clinical trial leads do not always mean better recruitment.
Referral quality starts with screening, records, documentation, and clearer site handoffs.
servahealth.com/patient-supp…
#ClinicalTrials
The next era of biomanufacturing is not only about being ready for the next crisis.
It is about turning pandemic-era speed, flexibility, and coordination into sustainable manufacturing capability. @biospace
biospace.com/drug-developmen…
#Biomanufacturing #DrugDevelopment #LifeScience
Specialty therapy access can stall after approval, benefits checks, or prescription routing.
Strong support keeps context moving so patients face fewer gaps between prescription and therapy.
servahealth.com/patient-supp…
#PatientAccess
Adherence is not just a patient behavior. It is a signal of how well a clinical trial is supporting the people and sites carrying it forward.
As protocols become more complex, patient centricity has to show up operationally.
clinicalresearchnewsonline.c…
For many specialty therapies, a prescription is only the start.
Patients may still need benefits verification, prior authorization, affordability support, pharmacy coordination, and follow-up before treatment can begin.
servahealth.com/patient-supp…
#PatientSupport #PatientAccess
Clinical trial enrollment remains one of the industry’s most persistent challenges.
That message aligns closely with where clinical research needs to go next.
Worth a read:
fiercebiotech.com/cro/dpharm…
#DPHARM #DPHARM2026 #ClinicalTrials #PatientRecruitment
Digital health technologies can make clinical trials more flexible.
servahealth.com/patient-supp…
But a wearable, app, sensor, or eCOA tool does not automatically create a better participant experience.
#ClinicalTrials #DigitalHealth #PatientEngagement #PatientSupport
PDUFA VIII could shape the next five years of FDA review priorities.
that means questions around review transparency, CMC risk, U.S.-based trials, and more predictable pathways for small, complex patient populations. @biospace
Worth a read:
biospace.com/fda/rare-diseas…
Digital health technologies can make clinical trials more flexible, but devices are only part of the experience.
A digital tool should reduce burden, not relocate it. Success depends on usability, training, reminders, support, and human follow-up.
servahealth.com/patient-supp…
Incomplete corrective actions rarely stay contained.
The lesson is relevant across regulated life sciences operations: a CAPA is only as strong as the investigation behind it.
pharmtech.com/view/two-audit…
#Pharma #QualityAssurance #Compliance #LifeSciences
A strong patient support program is built before the first patient enters the program.
The best PSPs define workflows, responsibilities, escalation paths, and technology connections early so teams are ready when patients need support.
servahealth.com/patient-supp…
#PatientAccess
Community-based clinical trials can make participation more practical, but proximity alone is not enough.
Patients still need clear communication, coordination, follow-up, and support that fits real life.
servahealth.com/patient-supp…
#ClinicalTrials #PatientSupport
